
I am extremely concerned about the number of known terrorists and criminals who have come across our southern border as a result of the weakness.
On the public record
Every politician on the site, every statement on file. Search, filter, and read the public record.
8,900+·quotes on file

I am extremely concerned about the number of known terrorists and criminals who have come across our southern border as a result of the weakness.

So we can't let this happen, right? I mean, this is a vulnerability for the safety and security of our country, is it not?

I would rather see those resources go toward stopping forced labor materials from coming into our country, interdicting those drugs.

We expect better of the VA medical care system. Our veterans deserve better.

The Pharmacy Benefit Manager (PBM) Transparency Act (S. 127) requires transparency reporting by PBMs to shine sunlight on prices and fees associated with prescription drugs.

The Pharmacy Benefit Manager (PBM) Transparency Act (S. 127) requires transparency reporting by PBMs to shine sunlight on prices and fees associated with prescription drugs.

Prohibits deceptive, unfair pricing schemes, including spread pricing and arbitrary clawbacks of payments made to pharmacies.

The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices.

Something ought to get done this Congress, considering the fact that there is already a bill out of Judiciary, a bill out of Commerce.

Prohibits deceptive, unfair pricing schemes, including spread pricing and arbitrary clawbacks of payments made to pharmacies.

I believe the key way that we can solve high prescription drug prices is to have more transparency.

In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.

The Prescription Pricing for the People bill requires the FTC to study pharmaceutical intermediaries, including vertical integration.

This bill puts sunshine on PBMs and saves taxpayers $740 million.

In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.

Something ought to get done this Congress, considering the fact that there is already a bill out of Judiciary, a bill out of Commerce.

The current drug price system is so opaque that it is easy to see why there are many questions about PBM motives and practices.

This bill puts sunshine on PBMs and saves taxpayers $740 million.